Brief: Immucell Corp Says Anticipates No Change To Preliminary Sales Results For Q3 Of 2022 That Were Disclosed On October 5
10/11/2022 22:02
Nov 10 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL CORP SAYS EXPECTS TO FILE ITS QUARTERLY REPORT ON
FORM
10-Q AFTER MARKET CLOSES ON MONDAY, NOVEMBER 21
* IMMUCELL CORP SAYS CO MAKING FILING ON DELAYED BASIS TO
ALLOW
TIME TO RESTATE FINANCIAL STATEMENTS FOR QUARTERS ENDED MARCH
31, AND JUNE 30
* IMMUCELL CORP SAYS ANTICIPATES NO CHANGE TO PRELIMINARY
SALES
RESULTS FOR Q3 OF 2022 THAT WERE DISCLOSED ON OCTOBER 5
Source text for Eikon: ID:nGNX6rx4vK
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year